Stocks
AxoGen (AXGN) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 79.0% | 85.1% | 127.8% | 189.9% | 248.4% | ||||
| Changes by years, y/y, % | +65pp | +6pp | -85pp | +62pp | +1.3% | ||||
AxoGen. R&D/CAPEX, %
AxoGen. R&D/CAPEX, changes, pp
AxoGen (AXGN) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 146.6% | 157.4% | 178.9% | 410.9% | 552.5% | 248.4% | ||
| Changes by years, y/y, % | +35pp | -5pp | +24pp | +310pp | +406pp | |||
| Changes by quarters, q/q, % | +46pp | +11pp | +22pp | +232pp | +142pp | |||
